title: Amyotrophic lateral sclerosis: a long preclinical period?
abstract: The onset of amyotrophic lateral sclerosis (ALS) is conventionally considered as commencing with the recognition of clinical symptoms. We propose that, in common with other neurodegenerations, the pathogenic mechanisms culminating in ALS phenotypes begin much earlier in life. Animal models of genetically determined ALS exhibit pathological abnormalities long predating clinical deficits. The overt clinical ALS phenotype may develop when safety margins are exceeded subsequent to years of mitochondrial dysfunction, neuroinflammation or an imbalanced environment of excitation and inhibition in the neuropil. Somatic mutations, the epigenome and external environmental influences may interact to trigger a metabolic cascade that in the adult eventually exceeds functional threshold. A long preclinical and subsequent presymptomatic period pose a challenge for recognition, since it offers an opportunity for protective and perhaps even preventive therapeutic intervention to rescue dysfunctional neurons. We suggest, by analogy with other neurodegenerations and from SOD1 ALS mouse studies, that vulnerability might be induced in the perinatal period.
authors.affiliation: Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: Andrew
authors.initials: A
authors.lastname: Eisen
authors.affiliation: Bushell Chair of Neurology, University of Sydney, Australia.
authors.forename: Matthew
authors.initials: M
authors.lastname: Kiernan
authors.affiliation: Wesley J. Howe Professor of Neurology at CUMC, Eleanor and Lou Gehrig MDA/ALS Research Center, The Neurological Institute of New York, Columbia University Medical Center, New York, USA.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Mitsumoto
authors.affiliation: Queen Mary University of London, UK Institute of Neuroscience, University of Lisbon, Portugal.
authors.forename: Michael
authors.initials: M
authors.lastname: Swash
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000175:diagnosis / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D062706:Prodromal Symptoms; D012307:Risk Factors; D009435:Synaptic Transmission / Q000502:physiology; D013997:Time Factors
keywords: ALS; Molecular Biology; Motor Neuron Disease; Neuroepidemiology; Neurotoxicology